Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.

Abstract

Early immunointervention in RA patients appears to be crucial to limit the development of joint damage. Cyclosporine A appears to be effective, well tolerated and safe in the long-term treatment of RA and can therefore be used as a first immunomodulatory drug in the armamentarium for the treatment of RA.